AuriNovo for Auricular Reconstruction

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

May 18, 2023

Study Completion Date

May 18, 2023

Conditions
Microtia
Interventions
COMBINATION_PRODUCT

AuriNovo

AuriNovo is a patient-specific, biologically natural, supportive base for surgical reconstruction of the external ear (auricle) in people born with microtia Grades II-IV. The construct is a 3D-bioprinted collagen hydrogel scaffold encapsulating the patient's own auricular cartilage cells (chondrocytes). The construct is printed in a size and shape that matches the contralateral ear for implantation into the patient.

Trial Locations (2)

78240

Microtia-Congenital Ear Deformity Institute, San Antonio

90211

John Reinisch, MD, Beverly Hills

Sponsors

Lead Sponsor

All Listed Sponsors
lead

3DBio Therapeutics

INDUSTRY

NCT04399239 - AuriNovo for Auricular Reconstruction | Biotech Hunter | Biotech Hunter